Journal of Clinical & Experimental Pharmacology

Department of Clinical Development, Procter and Gamble Technical Centres, Berkshire, United Kingdom

Publications

• Original Research Article   
  Management of Iron Deficiency Anemia with Fixed Dose Combination of Ferrous Gluconate, Multivitamins and Multi-mineral Capsule: A 12 Week, Open Label Single Arm Prospective, Non-Interventional (Observational) Study in Philippines
  Author(s): Christopher Joseph L. Soriano, V Abalos, CM Romero, R. Manalastas, G Villanueva, Poonam Sule*, Roger D Gibb, Sue Aspley and NS Comia
  
  Aim: The study evaluated the efficacy and safety of an Iron+multivitamin and multi mineral capsule (SB+) capsule in subjects with mild to moderate Iron Deficiency Anemia (IDA). Methods: This was a Phase IV/post-marketing, open label, single arm, prospective, non-interventional study to evaluate the SB+ capsule’s performance in real life scenario. The study enrolled 97 female subjects aged ≥ 15 years to ≤ 55 years (mean ± SD age: 34.9 ± 10.24 years) with mild to moderate IDA. The primary efficacy outcome was mean Hemoglobin (Hb) concentration after administering an SB+ capsule orally for up to 90 days. 66 subjects received 30 mg elemental iron once a day and 31 subjects received 60 mg elemental iron twice a day at baseline depending on their anemia status. The secondary efficacy outcomes were change i.. View more»
  

  DOI: 10.35248/2161-1459.23.13.385

  Abstract HTML PDF